The directors present the strategic report for the year ended 28 February 2025.

The directors are pleased to report another successful year of trading and consider turnover, gross profit margin, stock levels and net assets as the key performance indicators of the company.

During the year, the company generated income of £38.0m (2024: £34.4m), with a gross profit margin 15.5% (2024: 16.1%) achieved.

At the year end the company held stocks of £3.7m (2024: £2.7m) and had net assets of £1.4m (2024: £1.0m).

Turnover increased from the previous year supported by growth of customer bases spread across a variety of different healthcare professionals and wholesale businesses in wider geographic regions.

Cost of sales includes, but is not limited to, goods purchased for resale and the cost to distribute those goods to customers. The directors are pleased to note that volume efficiencies have been achieved in some areas of operations and further efficiencies have been achieved in the current year.

Profits remains in line with expectations, reflecting increases in costs as inflation continues to remain high in 2024/25 in comparison to previous years.

The directors therefore believe the company's position to be satisfactory, in line with expectations and the strategic direction agreed by the directors.

The company remains committed to being fully compliant with all relevant regulatory bodies and being the company of choice for customers and established suppliers.

The company continues to invest significantly in its workplace, infrastructure and service capability to achieve these objectives with high levels of quality compliance and to ensure it continues to be seen as the preferred choice within its core market where it operates. Other streams of revenue such as NHS prescription dispensing have continued to increase as well as revenue outside of the UK (Rest of the world).

The directors are not aware of any significant risks facing the company in the next twelve months, the directors are expecting the company’s performance to be relatively stable into 2026. Medium term uncertainties facing the company may primarily be linked to low UK economic growth with geo-political tensions in Europe and the Middle-East. The company continues to be well established within its current markets and therefore any economic downturn within the UK over the medium term may be somewhat mitigated based on the company’s strong reputation and dynamic market position by leveraging on a wide range of customer types and locations while also holding a deep and broad portfolio of products for our customers.

The principal ongoing general business risks include:

Increase in operating costs including but not limited to human resources costs. The directors continue to invest and plan in stream-lining the company to mitigate this risk such as upskilling existing teams with continued investment into I.T and outsourcing to seek further efficiencies in business processes and using robotics, software and A.I where safe and appropriate. Energy cost increases continued to be mitigated where possible through investment planning on vehicles and buildings infrastructure.

Risks in disruption of supply chains linked to possible wider wars around Ukraine and the Middle East - supply chain risks have been managed in the past (such as during the Covid pandemic) by maintaining a close working relationship with major manufacturers. Forecasting for adequate stocks to be procured while redundant supply chains are in place for alternative products. I.T systems are ready to quickly adapt to help our teams engage with customers leveraging off our large product database.

Risk of competition - Strong customer relationships, built on excellent products and customer service, and a reputation as a premium medical distributor helps to reduce the risk of competition. While this risk is currently well- managed with increased growth in 2024/25, the directors continue to monitor the competitive landscape.

Cash flow and liquidity risk - the company currently mitigates risk by actively managing its cash flow through various policies such as, the company’s tight credit control procedures, stock purchasing regimes with just-in-time inventory controls or working with suppliers on consignment stock / order fulfilment regimes. With the robust cash position of the company and regular sales demand from a broad range of customers, this risk has been mitigated to a satisfactory level. The directors note the CBILS loan has continued to be re-paid in line with the bank’s expectations despite the increase in interest rates over recent years, and with interest rates expected to hold/decline somewhat as inflation settles, this will also help the company’s cash position as an added bonus. It is expected the Covid loan is fully re-paid in less than 6 months from the date of approval of these financial statement, in line with the original bank agreement.

Credit risk - The company's policies are aimed at minimising such risk and any losses arising from other parties failing to discharge their obligations. Customers are required to satisfy credit worthiness procedures prior to credit being provided,. The directors consider that this risk has been mitigated to a satisfactory level. Additional insurance has also been undertaken to support mitigations against major disruptions such as a future pandemic.

The directors noted that a major UK recession was avoided in 2024 despite the global economic uncertainty and instability of the pound sterling in 2024. The recent Bank of England and other fiscal institutions’ forecasts of the UK economy over the forthcoming year are cautiously positive in 2025 for the country and consumers. The company remains resilient with such risks linked to consumer income fluctuations by way of a wide spread of varied customer group types across the UK (and in turn a variety of patient demographics and treatment needs). The company continues to hold a strong trusted reputation as a premium choice distributor for a growing base of patients/healthcare practitioners and suppliers.

Heightened global tensions and an increase in global conflicts may have increased political and economic ramifications in the medium term. The directors have carried out an updated assessment of potential geo-political impacts on the company, including the analysis of mitigation measures and uncertainties. The company does not operate in any areas of ongoing conflict and has no key suppliers or customers located in these regions.

The Board’s assessment of ongoing geopolitical events is that the business continues not to be directly impacted by these events, however the directors acknowledge that there may be some indirect impact on the company based on how the UK government and its allies strategies within the international community e.g. possible short term impacts in increased oil global prices, delayed international shipping routes, global I.T infrastructure resilience, adequate availability of energy/electricity in UK; the group has taken such factors into account during the going concern assessment, and will continue to take proactive actions while monitoring impacts, and respond accordingly.

However, the are confident that the company's strong management of cash flow and resilient supply chain planning with agile management structures and over 20 years experience since the company was established in 2005, ensures the group is well placed to adapt to changes in the domestic and global landscape.

The business climate remains challenging in a low UK growth economy, although demand is relatively stable - the company continues to find new and innovative routes to market and to build-on established partnerships with multiple brands.

Going Concern

After reviewing the company's forecasts and projections, the directors have reasonable expectation that the company can remain a viable going concern for the foreseeable future. The company therefore continues to adopt the going concern basis in preparing the financial statements.

On behalf of the board

The directors present their annual report and financial statements for the year ended 28 February 2025.

The principal activity of the company continued to be that of the wholesale and retail trading of pharmaceutical products and research, development and sale of information technology projects.

The results for the year are set out on page 9.

No ordinary dividends were paid during the current or prior year. The directors do not recommend payment of a final dividend.

The directors who held office during the year and up to the date of signature of the financial statements were as follows:

The strategic report contains details of the principal risks and uncertainties which are faced by the company.

The directors are confident about the future prospects for the company, having undertaken a review of the company's performance post-year end.

The auditor, Forvis Mazars LLP, is deemed to be reappointed under section 487(2) of the Companies Act 2006.

The directors are responsible for preparing the annual report and the financial statements in accordance with applicable law and regulations.

Company law requires the directors to prepare financial statements for each financial year. Under that law the directors have elected to prepare the financial statements in accordance with United Kingdom Generally Accepted Accounting Practice (United Kingdom Accounting Standards and applicable law). Under company law the directors must not approve the financial statements unless they are satisfied that they give a true and fair view of the state of affairs of the company and of the profit or loss of the company for that period. In preparing these financial statements, the directors are required to:

• select suitable accounting policies and then apply them consistently;

• make judgements and accounting estimates that are reasonable and prudent;

• state whether applicable UK Accounting Standards have been followed, subject to any material departures disclosed and explained in the financial statements;

• prepare the financial statements on the going concern basis unless it is inappropriate to presume that the company will continue in business.

The directors are responsible for keeping adequate accounting records that are sufficient to show and explain the company’s transactions and disclose with reasonable accuracy at any time the financial position of the company and enable them to ensure that the financial statements comply with the Companies Act 2006. They are also responsible for safeguarding the assets of the company and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.

So far as each person who was a director at the date of approving this report is aware, there is no relevant audit information of which the company’s auditor is unaware. Additionally, the directors individually have taken all the necessary steps that they ought to have taken as directors in order to make themselves aware of all relevant audit information and to establish that the company’s auditor is aware of that information.

We have audited the financial statements of Order Line Limited (the ‘company’) for the year ended 28 February 2025 which comprise the statement of comprehensive income, balance sheet, statement of changes in equity and notes to the financial statements, including a summary of significant accounting policies.

The financial reporting framework that has been applied in their preparation is applicable law and United Kingdom Accounting Standards, including FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (United Kingdom Generally Accepted Accounting Practice).

In our opinion the financial statements:

• give a true and fair view of the state of the company's affairs as at 28 February 2025 and of its profit for the year then ended;

• have been properly prepared in accordance with United Kingdom Generally Accepted Accounting Practice; and

• have been prepared in accordance with the requirements of the Companies Act 2006.

Basis for opinion

We conducted our audit in accordance with International Standards on Auditing (UK) (ISAs (UK)) and applicable law. Our responsibilities under those standards are further described in the “Auditor’s responsibilities for the audit of the financial statements” section of our report. We are independent of the company in accordance with the ethical requirements that are relevant to our audit of the financial statements in the UK, including the FRC’s Ethical Standard, and we have fulfilled our other ethical responsibilities in accordance with these requirements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.

Conclusions relating to going concern

In auditing the financial statements, we have concluded that the directors’ use of the going concern basis of accounting in the preparation of the financial statements is appropriate.

Based on the work we have performed, we have not identified any material uncertainties relating to events or conditions that, individually or collectively, may cast significant doubt on the company's ability to continue as a going concern for a period of at least twelve months from when the financial statements are authorised for issue.

Our responsibilities and the responsibilities of the directors with respect to going concern are described in the relevant sections of this report.

Other information

The other information comprises the information included in the annual report, other than the financial statements and our auditor’s report thereon. The directors are responsible for the other information contained within the annual report. Our opinion on the financial statements does not cover the other information and, except to the extent otherwise explicitly stated in our report, we do not express any form of assurance conclusion thereon.

Our responsibility is to read the other information and, in doing so, consider whether the other information is materially inconsistent with the financial statements or our knowledge obtained in the course of the audit, or otherwise appears to be materially misstated. If we identify such material inconsistencies or apparent material misstatements, we are required to determine whether this gives rise to a material misstatement in the financial statements themselves. If, based on the work we have performed, we conclude that there is a material misstatement of this other information, we are required to report that fact.

We have nothing to report in this regard.

Opinions on other matters prescribed by the Companies Act 2006

In our opinion, based on the work undertaken in the course of our audit:

• the information given in the strategic report and the directors' report for the financial year for which the financial statements are prepared is consistent with the financial statements; and

• the strategic report and the directors' report have been prepared in accordance with applicable legal requirements.

In the light of the knowledge and understanding of the company and its environment obtained in the course of the audit, we have not identified material misstatements in the strategic report and the directors' report.

We have nothing to report in respect of the following matters where the Companies Act 2006 requires us to report to you if, in our opinion:

• adequate accounting records have not been kept, or returns adequate for our audit have not been received from branches not visited by us; or

• the financial statements are not in agreement with the accounting records and returns; or

• certain disclosures of directors' remuneration specified by law are not made; or

• we have not received all the information and explanations we require for our audit.

As explained more fully in the directors’ responsibilities statement set out on page 4, the directors are responsible for the preparation of the financial statements and for being satisfied that they give a true and fair view, and for such internal control as the directors determine is necessary to enable the preparation of financial statements that are free from material misstatement, whether due to fraud or error.

In preparing the financial statements, the directors are responsible for assessing the company’s ability to continue as a going concern, disclosing, as applicable, matters related to going concern and using the going concern basis of accounting unless the directors either intend to liquidate the company or to cease operations, or have no realistic alternative but to do so.

Our objectives are to obtain reasonable assurance about whether the financial statements as a whole are free from material misstatement, whether due to fraud or error, and to issue an auditor’s report that includes our opinion. Reasonable assurance is a high level of assurance but is not a guarantee that an audit conducted in accordance with ISAs (UK) will always detect a material misstatement when it exists. Misstatements can arise from fraud or error and are considered material if, individually or in the aggregate, they could reasonably be expected to influence the economic decisions of users taken on the basis of the financial statements.

The extent to which our procedures are capable of detecting irregularities, including fraud is detailed below.

Irregularities, including fraud, are instances of non-compliance with laws and regulations. We design procedures in line with our responsibilities, outlined above, to detect material misstatements in respect of irregularities, including fraud.

Based on our understanding of the company and its industry, we considered that non-compliance with the following laws and regulations might have a material effect on the financial statements: employment regulation, health and safety regulation and anti-money laundering regulation.

To help us identify instances of non-compliance with these laws and regulations, and in identifying and assessing the risks of material misstatement in respect to non-compliance, our procedures included, but were not limited to:

• Inquiring of management and, where appropriate, those charged with governance, as to whether the company is in compliance with laws and regulations, and discussing their policies and procedures regarding compliance with laws and regulations;

• Inspecting correspondence, if any, with relevant licensing or regulatory authorities;

• Communicating identified laws and regulations to the engagement team and remaining alert to any indications of non-compliance throughout our audit; and

• Considering the risk of acts by the company which were contrary to applicable laws and regulations, including fraud.

We also considered those laws and regulations that have a direct effect on the preparation of the financial statements, such as tax legislation, pension legislation, the Companies Act 2006.

In addition, we evaluated the directors’ and management’s incentives and opportunities for fraudulent manipulation of the financial statements, including the risk of management override of controls, and determined that the principal risks related to posting manual journal entries to manipulate financial performance, revenue recognition (which we pinpointed to the cut-off risk), and significant one-off or unusual transactions.

Our audit procedures in relation to fraud included but were not limited to:

• Making enquiries of the directors and management on whether they had knowledge of any actual, suspected or alleged fraud;

• Gaining an understanding of the internal controls established to mitigate risks related to fraud;

• Discussing amongst the engagement team the risks of fraud; and

• Addressing the risks of fraud through management override of controls by performing journal entry testing.

There are inherent limitations in the audit procedures described above and the primary responsibility for the prevention and detection of irregularities including fraud rests with management. As with any audit, there remained a risk of non-detection of irregularities, as these may involve collusion, forgery, intentional omissions, misrepresentations or the override of internal controls.

A further description of our responsibilities for the audit of the financial statements is located on the Financial Reporting Council’s website at www.frc.org.uk/auditorsresponsibilities. This description forms part of our auditor’s report.

Use of our report

This report is made solely to the company's members, as a body, in accordance with Chapter 3 of Part 16 of the Companies Act 2006. Our audit work has been undertaken so that we might state to the company's members those matters we are required to state to them in an auditor's report and for no other purpose. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than the company and the company's members as a body, for our audit work, for this report, or for the opinions we have formed.

The statement of comprehensive income has been prepared on the basis that all operations are continuing operations.

There are no recognised gains and losses other than those passing through the statement of comprehensive income.

The notes on pages 12 to 23 form part of these financial statements.

The notes on pages 12 to 23 form part of these financial statements.

The notes on pages 12 to 23 form part of these financial statements.

Order Line Limited is a private company limited by shares incorporated in England and Wales. The registered office is 7 Prince William Road, Loughborough, England, LE11 5GU.

These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006.

The financial statements are prepared in Pound sterling, which is the functional currency of the company. Monetary amounts in these financial statements are rounded to the nearest £.

The financial statements have been prepared under the historical cost convention. The principal accounting policies adopted are set out below.

This company is a qualifying entity for the purposes of FRS 102, being a member of a group where the parent of that group prepares publicly available consolidated financial statements, including this company, which are intended to give a true and fair view of the assets, liabilities, financial position and profit or loss of the group. The company has therefore taken advantage of exemptions from the following disclosure requirements:

• Section 4 ‘Statement of Financial Position’: Reconciliation of the opening and closing number of shares;

• Section 7 ‘Statement of Cash Flows’: Presentation of a statement of cash flow and related notes and disclosures;

• Section 11 ‘Basic Financial Instruments’ and Section 12 ‘Other Financial Instrument Issues’: Carrying amounts, interest income/expense and net gains/losses for each category of financial instrument; basis of determining fair values; details of collateral, loan defaults or breaches, details of hedges, hedging fair value changes recognised in profit or loss and in other comprehensive income;

• Section 33 ‘Related Party Disclosures’: Compensation for key management personnel.

The financial statements of the company are consolidated in the financial statements of Skynet Ltd. These consolidated financial statements are available from its registered office, 7 Prince William Road, Loughborough, LE11 5GU.

Atruet the time of approving the financial statements, the directors have a reasonable expectation that the company has adequate resources to continue in operational existence for the foreseeable future. Thus the directors continue to adopt the going concern basis of accounting in preparing the financial statements.

Turnover is recognised at the fair value of the consideration received or receivable for goods supplied net of discounts and Value Added Tax.

Turnover from the sale of goods is recognised when the significant risks and rewards of ownership of the goods have passed to the buyer (usually on despatch of the goods), the amount of turnover can be measured reliably, it is probable that the economic benefits associated with the transaction will flow to the entity and the costs incurred or to be incurred in respect of the transaction can be measured reliably.

Intangible assets are initially recorded at cost, and are subsequently stated at cost less any accumulated amortisation and impairment losses.

Amortisation is recognised so as to write off the cost of assets less their residual values over their useful lives on the following annual basis:

Tangible fixed assets are initially measured at cost and subsequently measured at cost, net of depreciation and any impairment losses.

Depreciation is recognised so as to write off the cost of assets less their residual values over their useful lives on the following annual bases:

The gain or loss arising on the disposal of an asset is determined as the difference between the sale proceeds and the carrying value of the asset, and is credited or charged to profit or loss.

A review for indicators of impairment is carried out at each reporting date, with the recoverable amount being estimated where such indicators exist. Where the carrying value exceeds the recoverable amount, the asset is impaired accordingly. Prior impairments are also reviewed for possible reversal at each reporting date.

Stocks are stated at the lower of cost and estimated selling price less costs to complete and sell.

At each reporting date, an assessment is made for impairment. Any excess of the carrying amount of stocks over its estimated selling price is recognised as an impairment loss in the Statement of Comprehensive Income. Reversals of impairment losses are also recognised in the Statement of Comprehensive Income.

Cash and cash equivalents are basic financial assets and include cash in hand, deposits held with banks and cash held by payment platforms.

Basic financial assets, which include debtors, loans to fellow group companies and cash and bank balances, are initially measured at transaction price including transaction costs and are subsequently carried at amortised cost using the effective interest method unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest. Financial assets classified as receivable within one year are not amortised.

Other financial assets, including investments in equity instruments which are not subsidiaries, associates or joint ventures, are initially measured at fair value, which is normally the transaction price. Such assets are subsequently carried at fair value and the changes in fair value are recognised in profit or loss, except that investments in equity instruments that are not publicly traded and whose fair values cannot be measured reliably are measured at cost less impairment.

Financial assets, other than those held at fair value through profit and loss, are assessed for indicators of impairment at each reporting end date.

Financial assets are derecognised only when the contractual rights to the cash flows from the asset expire or are settled, or when the company transfers the financial asset and substantially all the risks and rewards of ownership to another entity, or if some significant risks and rewards of ownership are retained but control of the asset has transferred to another party that is able to sell the asset in its entirety to an unrelated third party.

Basic financial liabilities, including creditors, finance leases and bank loans, are initially recognised at transaction price unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future payments discounted at a market rate of interest. Financial liabilities classified as payable within one year are not amortised.

Debt instruments are subsequently carried at amortised cost, using the effective interest rate method.

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Amounts payable are classified as current liabilities if payment is due within one year or less. If not, they are presented as non-current liabilities. Trade creditors are recognised initially at transaction price and subsequently measured at amortised cost using the effective interest method.

Derivatives, including interest rate swaps and forward foreign exchange contracts, are not basic financial instruments. Derivatives are initially recognised at fair value on the date a derivative contract is entered into and are subsequently re-measured at their fair value. Changes in the fair value of derivatives are recognised in profit or loss in finance costs or finance income as appropriate, unless hedge accounting is applied and the hedge is a cash flow hedge.

Debt instruments that do not meet the conditions in FRS 102 paragraph 11.9 are subsequently measured at fair value through profit or loss. Debt instruments may be designated as being measured at fair value through profit or loss to eliminate or reduce an accounting mismatch or if the instruments are measured and their performance evaluated on a fair value basis in accordance with a documented risk management or investment strategy.

Financial liabilities are derecognised when the company’s contractual obligations expire or are discharged or cancelled.

The tax expense represents the sum of the tax currently payable and deferred tax.

The tax currently payable is based on taxable profit for the year. Taxable profit differs from net profit as reported in the profit and loss account because it excludes items of income or expense that are taxable or deductible in other years and it further excludes items that are never taxable or deductible. The company’s liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the reporting end date.

Deferred tax liabilities are generally recognised for all timing differences between taxable profits and profits reported in the financial statements. Unrelieved tax losses and other deferred tax assets are recognised when it is probably that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Deferred tax is calculated at the tax rates that have been enacted or substantively enacted by the reporting date and are expected to apply in the period to the reversal of the timing difference.

The costs of short-term employee benefits are recognised as a liability and an expense.

The cost of any unused holiday entitlement is recognised in the period in which the employee’s services are received.

Termination benefits are recognised immediately as an expense when the company is demonstrably committed to terminate the employment of an employee or to provide termination benefits.

Payments to defined contribution retirement benefit schemes are charged as an expense as they fall due.

Leases are classified as finance leases whenever the terms of the lease transfer substantially all the risks and rewards of ownership to the lessees. All other leases are classified as operating leases.

Assets held under finance leases are recognised as assets at the lower of the assets fair value at the date of inception and the present value of the minimum lease payments. The related liability is included in the balance sheet as a finance lease obligation. Lease payments are treated as consisting of capital and interest elements. The interest is charged to profit or loss so as to produce a constant periodic rate of interest on the remaining balance of the liability.

Rentals payable under operating leases, including any lease incentives received, are charged to profit or loss on a straight line basis over the term of the relevant lease.

Transactions in currencies other than pounds sterling are recorded at the rates of exchange prevailing at the dates of the transactions. At each reporting end date, monetary assets and liabilities that are denominated in foreign currencies are retranslated at the rates prevailing on the reporting end date. Gains and losses arising on translation in the period are included in profit or loss.

In the application of the company’s accounting policies, the directors are required to make judgements, estimates and assumptions about the carrying amount of assets and liabilities that are not readily apparent from other sources. The estimates and associated assumptions are based on historical experience and other factors that are considered to be relevant. Actual results may differ from these estimates.

The estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognised in the period in which the estimate is revised where the revision affects only that period, or in the period of the revision and future periods where the revision affects both current and future periods.

There are considered to be no judgements, estimates or assumptions which have a significant risk of causing a material adjustment to the carrying value of assets and liabilities.

Turnover is wholly attributable to the principal activity of the company.

The average monthly number of persons (including directors) employed by the company during the year was:

Their aggregate remuneration comprised:

The actual charge for the year can be reconciled to the expected charge for the year based on the profit or loss and the standard rate of tax as follows:

The net carrying value of tangible fixed assets includes the following in respect of assets held under finance leases.

A provision of £12,483 (2024: £6,897) has been made for short-dated stock. The carrying value of stock at the year end includes this provision.

Interest is charged on amounts owed by group undertakings at HMRC's Official Rate of Interest, which was 2.25% per annum during the year ended 28 February 2025. Balances are repayable upon demand.

At the year end, the company did not consider any provision for bad or doubtful debts to be required (2024: no provision required).

Interest is payable on amounts owed to group undertakings at HMRC's Official Rate of Interest which was 2.25% per annum during the year ended 28 February 2025. Balances are repayable upon demand.

The bank loan is secured by an unlimited debenture secured against the assets of the company.

Finance lease payments represent amounts payable by the company for motor vehicles. Finance lease obligations are secured on the asset to which they relate.

The following are the major deferred tax liabilities and assets recognised by the company and movements thereon:

The deferred tax liability set out above is expected to reverse within 7 years and relates to accelerated capital allowances that are expected to mature within the same period.

The company operates a defined contribution pension scheme for all qualifying employees. The assets of the scheme are held separately from those of the company in an independently administered fund.

Included within closing creditors are contributions of £7,665 (2024: £nil) in respect of the year.

The company has one class of ordinary shares which carry voting, dividend and capital distribution rights.

Called up share capital

This represents the nominal value of shares in issue.

Profit and loss account

This reserve records retained earnings and accumulated losses.

At the reporting end date the company had outstanding commitments for future minimum lease payments under non-cancellable operating leases, which fall due as follows:

As a subsidiary undertaking of Skynet Ltd, the company has taken advantage of the exemption under Section 33.1A of FRS 102 from disclosing transactions with other members that are wholly owned within the group.

During the year the company made advances totalling £411,053 (2024: £162,046) to various connected parties of the directors or the company, and received repayments totalling £12,000 (2024: £22,000). At the year end £653,366 (2024: £254,313) was owed to the company from these connected parties.

During the year, the company made sales to a business operated by a close family member of a director totalling £5,598 (2024: £11,925). At the year end £1,763 (2024: £1,016) was due to the company from these related parties.

During the year, the company made purchases from a company under common control of £624,500 (2024: £610,000). At the year end £nil (2024: £47,000) was due from the company to the company under common control.

During the year, the company made payments totalling £1,133 (2024: £57,870) to the directors. At 28 February 2025 £18,935 was owed to the directors by the company (2024: £20,068).

The company's immediate and ultimate parent is Skynet Ltd, incorporated in England & Wales.

The most senior parent entity producing publicly available financial statement is Skynet Ltd. These financial statements are available upon request from 7 Prince William Road, Loughborough, LE11 5GU.

The ultimate controlling parties are Mr M R and Mrs A Bhojani.